BlackRock Group’s Atara Biotherapeutics ATRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$86K Buy
240
+19
+9% +$6.81K ﹤0.01% 2842
2016
Q3
$119K Buy
221
+8
+4% +$4.31K ﹤0.01% 2770
2016
Q2
$121K Sell
213
-3
-1% -$1.7K ﹤0.01% 2717
2016
Q1
$103K Buy
216
+94
+77% +$44.8K ﹤0.01% 2738
2015
Q4
$80K Sell
122
-4
-3% -$2.62K ﹤0.01% 2732
2015
Q3
$99K Buy
126
+44
+54% +$34.6K ﹤0.01% 2696
2015
Q2
$109K Buy
+82
New +$109K ﹤0.01% 2710